Condition: Epiretinal Membrane · Dry Age Related Macular Degeneration · Macular Abnormalities · Sponsor: Carl Zeiss Meditec-Dublin CoCe
This study will measure how well PathFinder 1.0 detects retinal abnormalities on macular cube OCT B-scans by assessing its sensitivity and specificity.
This description comes directly from the study's public registry record.
Patricia Sha, Optometrist · 925-307-1588 · patricia.sha@zeiss.com
Always discuss trial participation with your own doctor first.
| Retina Associates | Tucson, Arizona, United States | Recruiting |
| Northern California Retina Vitreous Associates | Mountain View, California, United States | Recruiting |
| Premier Eyecare of San Francisco | San Francisco, California, United States | Completed |
| Nova Southeastern University College of Optometry | Fort Lauderdale, Florida, United States | Recruiting |
| Eyecare Medical Group | Portland, Maine, United States | Recruiting |
| Moyes Eye Center | Kansas City, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07680244